(Q40855806)

reason for preferred rank

24 September 2017

title

Homozygous C2 deficiency with fulminant lupus erythematosus. severe nephritis via the alternative complement pathway (English)

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

31 March 2023

Homozygous C2 deficiency with fulminant lupus erythematosus: severe nephritis via the alternative complement pathway (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A341897

31 March 2023

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

31 March 2023

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

31 March 2023

1 reference

A. Gewurz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A341897

31 March 2023

T. F. Lint

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A341897

31 March 2023

J. L. Roberts

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A341897

31 March 2023

H. Zeitz

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A341897

31 March 2023

H. Gewurz

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A341897

31 March 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=341897

31 March 2023

publication date

1 January 1978

1 reference

full work available at URL

24 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.1780210106

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

https://onlinelibrary.wiley.com/doi/full/10.1002/art.1780210106

31 March 2023

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

31 March 2023

published in

Arthritis & Rheumatology

1 reference

24 September 2017

Arthritis and Rheumatism

21

1

28–36

January 1978

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=341897

31 March 2023

volume

21

1 reference

24 September 2017

issue

1

1 reference

24 September 2017

page(s)

28-36

1 reference

Inherited Complement Deficiencies and Systemic Lupus Erythematosus: an Immunogenetic Puzzle

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FART.1780210106

Inherited C2 deficiency and systemic lupus erythematosus: studies on a family

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FART.1780210106

Inherited deficiency of the second component of complement. Rheumatic disease associations

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

31 March 2023

Transplantation reviews

2

32

43

Jersild

1976

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

Hereditary C2 deficiency. Association with skin lesions resembling the discoid lesion of systemic lupus erythematosus

31 March 2023

5

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

The complement system in chronic glomerulonephritis: Three newly associated aberrations

31 March 2023

7

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

C2 deficiency. Development of lupus erythematosus

31 March 2023

8

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

Genetic Linkage Between the HL-A System and a Deficit of the Second Component (C2) of Complement

31 March 2023

9

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

Genetic deficiency of the second component of complement (C2) associated with systemic lupus erythematosus. Relation of the complement abnormality and disease manifestations

31 March 2023

12

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

Deficiency of the sixth component of complement in rabbits with an inherited complement defect

31 March 2023

15

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

Absence of the sixth component of complement in a patient with repeated episodes of meningococcal meningitis

31 March 2023

16

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

31 March 2023

17

24

543a

Lint

1976

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

31 March 2023

Federation Proceedings

23

34

983

Polhill

1975

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

Alternative pathway of complement: demonstration and characterization of initiating factor and its properdin-independent function

31 March 2023

24

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

31 March 2023

Federation Proceedings

27

35

493

Behrends

1976

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

Evidence for linkage between HL-A histocompatibility genes and those involved in the synthesis of the second component of complement.

31 March 2023

31

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

Hereditary C2 deficiency: Genetic studies and association with the HL-A system

31 March 2023

32

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

Mixed lymphocyte culture determinants and C2 deficiency: LD-7a associated with C2 deficiency in four families

31 March 2023

33

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

The chromosomal order of genes controlling the major histocompatibility complex, properdin factor B, and deficiency of the second component of complement

31 March 2023

36

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

Genetic loci of components of the classical and alternate pathway of complement activation: A new dimension of the immunogenetic linkage group (HLA) on chromosome 6 in man

31 March 2023

37

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

31 March 2023

Linkage of HL-A and GBG

38

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

Anti-DNA activity in systemic lupus erythematosus. A diagnostic and therapeutic guide

31 March 2023

40

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

Gamma G globulin subgroup composition of the glomerular deposits in human renal diseases

31 March 2023

44

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

Biosynthetic Defect in Monocytes from Human Beings with Genetic Deficiency of the Second Component of Complement

31 March 2023

45

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

Glomerular deposition of properdin in acute and chronic glomerulonephritis with hypocomplementemia

31 March 2023

46

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

Glomerular and dermal depostion of properdin in systemic lupus erythematosus.

31 March 2023

47

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

Metabolism of third complement component (C3) in nephritis. Involvement of the classic and alternate (properdin) pathways for complement activation

31 March 2023

48

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

Properdin and C3 Proactivator: Alternate Pathway Components in Human Glomerulonephritis

31 March 2023

49

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

Mixed connective tissue disease--an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA)

31 March 2023

50

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

Correlation of a Precipitin Reaction to an RNA-Protein Antigen and a Low Prevalence of Nephritis in Patients with Systemic Lupus Erythematosus

31 March 2023

51

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

Characteristics of patients with serum antibodies to extractable nuclear antigens

31 March 2023

52

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

Formation of a hemolytically active cellular intermediate by the interaction between properdin factors B and D and the activated third component of complement

31 March 2023

53

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

Mechanism of injury of virus-infected cells by antiviral antibody and complement: participation of IgG, F(ab')2, and the alternative complement pathway

31 March 2023

54

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

Haemolytic diffusion plate assays for factors B and D of the alternative pathway of complement activation

31 March 2023

55

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

31 March 2023

Identifiers

1 reference

24 September 2017

1 reference